| A New In Vivo Model to Study Protective Immunity to Zika Virus Infection in Mice With Intact Type I Interferon Signaling L Nazerai, AS Schøller, POS Rasmussen, S Buus, A Stryhn, ... Frontiers in immunology 9, 593, 2018 | 46 | 2018 |
| A ‘furry-tale’of Zika virus infection: what have we learned from animal models? L Nazerai, J Pravsgaard Christensen, A Randrup Thomsen Viruses 11 (1), 29, 2019 | 27 | 2019 |
| Local Antigen Encounter Is Essential for Establishing Persistent CD8+ T-Cell Memory in the CNS AS Schøller, M Fonnes, L Nazerai, JP Christensen, AR Thomsen Frontiers in immunology 10, 351, 2019 | 23 | 2019 |
| PB1 as a potential target for increasing the breadth of T-cell mediated immunity to Influenza A IEM Uddbäck, MA Steffensen, SR Pedersen, L Nazerai, AR Thomsen, ... Scientific Reports 6 (1), 35033, 2016 | 17 | 2016 |
| Functionally Competent, PD-1+ CD8+ Trm Cells Populate the Brain Following Local Antigen Encounter AS Schøller, L Nazerai, JP Christensen, AR Thomsen Frontiers in Immunology 11, 595707, 2021 | 14 | 2021 |
| Effector CD8 T cell-dependent zika virus control in the CNS: A matter of time and numbers L Nazerai, AS Schøller, MR Bassi, S Buus, A Stryhn, JP Christensen, ... Frontiers in Immunology 11, 1977, 2020 | 13 | 2020 |
| Early life vaccination: Generation of adult-quality memory CD8+ T cells in infant mice using non-replicating adenoviral vectors L Nazerai, MR Bassi, IEM Uddback, PJ Holst, JP Christensen, ... Scientific reports 6 (1), 38666, 2016 | 6 | 2016 |
| Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade L Nazerai, SC Willis, P Yankilevich, L Di Leo, FM Bosisio, A Frias, ... OncoImmunology 12 (1), 2158610, 2023 | 4 | 2023 |
| Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma A Frias, L Di Leo, A Antoranz, L Nazerai, M Carretta, V Bodemeyer, ... Journal for immunotherapy of cancer 11 (3), 2023 | 2 | 2023 |
| An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome P Yankilevich, L Nazerai, SC Willis, K Schmiegelow, D De Zio, M Nielsen Cancer Immunology, Immunotherapy 73 (2), 22, 2024 | | 2024 |
| Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain L Nazerai, S Buus, A Stryhn, AR Thomsen, JP Christensen Viruses 13 (11), 2215, 2021 | | 2021 |
| Zika virus infection: a new in vivo model to define protective immunity L Nazerai, AS Scholler, S Buus, AS Buus, JP Christensen, AR Thomsen SCANDINAVIAN JOURNAL OF IMMUNOLOGY 86 (4), 287-288, 2017 | | 2017 |
| PB1 as a potential target for increasing the breadth of T-cell mediated immunity to Influenza A IEM Uddback, MA Steffensen, SR Pedersen, L Nazerai, AR Thomsen, ... The Journal of Immunology 198 (1_Supplement), 147.11-147.11, 2017 | | 2017 |
